PRAK Inhibitors

PRAK (p38-regulated/activated kinase), also referred to as mitogen-activated protein kinase (MAPK)-activated protein kinase (MAPKAPK)-5, is a ubiquitously expressed serine/threonine kinase regulated by p38α and p38β MAP kinases. Biochemicals that inhibit PRAK have many applications in biochemical and physiological research. Click on the product name to view detailed information such as the chemical structure and specific chemical properties for each of our PRAK Inhibitors. In stock PRAK Inhibitors are available for immediate shipping.

indicates a highly recommended product based on customer preference.

PRODUCT NAME/ApplicationCASCatalog #QUANTITYPriceCitationsRATING
CID 755673
A selective PKC, PKD, Plk, and HSP 27 inhibitor
10 mg
MK-2 Inhibitor III
A cell-permeable pyrrolopyridinyl compound that acts as a potent, selective, and ATP-biniding site-targeting MK-2/MAPKAP-K2 inhibitor
5 mg
A widely-used selective inhibitor of PKCδ
10 mg
25 mg
50 mg

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.